Project AWARE 2.0 to Improve Awareness, Willingness and Ability for Research and Enrollment in Clinical Research
1 other identifier
observational
131
1 country
1
Brief Summary
The Project AWARE 2.0 Survey is intended to gain knowledge about the feelings, attitudes, and beliefs of HD family members, care partners and others affected by HD towards the way drug trials and observational studies are communicated and conducted.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 26, 2024
CompletedFirst Posted
Study publicly available on registry
April 2, 2024
CompletedStudy Start
First participant enrolled
April 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 22, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 22, 2025
CompletedDecember 23, 2025
December 1, 2025
1.7 years
March 26, 2024
December 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Examine awareness
To examine prospective research participants' awareness, willingness, and ability to participate in clinical research for HD.
December 2024
Provide the HD research community with the insight.
Provide the HD research community with insight to design clinical studies and trials in the future.
December 2024
Eligibility Criteria
Must either have HD or be at risk for having HD.
You may qualify if:
- Participants must either have HD or be at risk for having HD
- Participants must be 18 years of age or older
- Participants must live in the United States
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Huntington Study Grouplead
- Roche Products Limitedcollaborator
- Neurotargeting LLCcollaborator
Study Sites (1)
Huntington Study Group
Rochester, New York, 14618, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amy Brown, MD, MS
HSG
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 26, 2024
First Posted
April 2, 2024
Study Start
April 10, 2024
Primary Completion
December 22, 2025
Study Completion
December 22, 2025
Last Updated
December 23, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- 2024
The Project AWARE 2.0 Survey is intended to gain knowledge about the feelings, attitudes, and beliefs of HD family members, care partners and others affected by HD towards the way drug trials and observational studies are communicated and conducted. Answers to these questions will provide valuable information to the HD research community when designing and conducting drug trials and observational studies.